Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron vs Desmopressin in Primary Nocturnal Enuresis
NCT05617664Unknown
- Sponsor
- Benha University
- Start
- Nov 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mirabegron in nocturnal enuresis (NE) (3 arms), sponsored by Benha University. Primary endpoint: Nocturnal enuresis improvement rate at 4 months. Status: unknown.
02
Drugs
mirabegron
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT05617664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05617664.